Clinical Drug Experience Knowledgebase

Ovarian Neoplasms (approved 1978)

Testicular Neoplasms (approved 1978)

Urinary Bladder Neoplasms (approved 1978)

Abdominal Neoplasms (Phase 2)

Acquired Immunodeficiency Syndrome (Phase 2)

Acute Kidney Injury (Phase 2)

Adenocarcinoma (Phase 4)

Adenocarcinoma of Lung (Phase 4)

Adenoma, Islet Cell (Phase 2)

Adrenal Gland Neoplasms (Phase 3)

Adrenocortical Carcinoma (Phase 3)

Albumin-Bound Paclitaxel (Phase 1/Phase 2)

Alzheimer Disease (Phase 1)

Androgens (Phase 1)

Anemia (Phase 4)

Angiogenesis Modulating Agents (Phase 2)

Anterior Cruciate Ligament Injuries (Phase 2)

Antineoplastic Agents (Phase 2)

Anus Neoplasms (Phase 3)

Anxiety Disorders (Phase 2)

Appendiceal Neoplasms (Phase 1)

Ascites (Phase 2)

Astrocytoma (Phase 1)

Bevacizumab (Phase 2)

Bile Duct Neoplasms (Phase 3)

Biliary Tract Neoplasms (Phase 3)

Biomarkers (Phase 2)

Bone Marrow Diseases (Phase 2)

Brain Neoplasms (Phase 3)

BRCA1 Protein (Phase 2)

Breast Neoplasms (Phase 3)

Breast Neoplasms, Male (Phase 1)

Brenner Tumor (Phase 1)

Bronchial Diseases (Phase 3)

Bronchial Neoplasms (Phase 2)

Burkitt Lymphoma (Phase 1/Phase 2)

Carboplatin (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Adenoid Cystic (Phase 2)

Carcinoma, Adenosquamous (Phase 2)

Carcinoma, Basal Cell (Phase 1/Phase 2)

Carcinoma, Bronchogenic (Phase 3)

Carcinoma, Endometrioid (Phase 1)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Merkel Cell (Phase 2)

Carcinoma, Mucoepidermoid (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Small Cell (Phase 3)

Carcinoma, Squamous Cell (Phase 4)

Carcinoma, Transitional Cell (Phase 3)

Carcinoma, Verrucous (Phase 3)

Cardiotoxicity (Phase 3)

Central Nervous System Neoplasms (Phase 3)

Chemical and Drug Induced Liver Injury (Phase 4)

Chemoradiotherapy (Phase 3)

Chemotherapy, Adjuvant (Phase 3)

Child (Phase 2)

Cholangiocarcinoma (Phase 3)

Chondrosarcoma (Phase 1/Phase 2)

Choriocarcinoma (Phase 3)

Choroid Plexus Neoplasms (Phase 3)

Circulating Tumor DNA (Phase 2)

Cisplatin (Phase 3)

Clonal Hematopoiesis (Phase 2)

Cognition Disorders (Phase 3)

Cognitive Dysfunction (Phase 1)

Colitis, Ulcerative (Phase 1/Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 3)

Cyclophosphamide (Phase 2)

Cysts (Phase 3)

Cytoreduction Surgical Procedures (Phase 2)

Death (Phase 2)

Depression (Phase 2)

Desmoplastic Small Round Cell Tumor (Phase 1)

Dexamethasone (Phase 2)

Digestive System Diseases (Phase 1/Phase 2)

Digestive System Neoplasms (Phase 2)

Disease-Free Survival (Phase 2/Phase 3)

Disease Progression (Phase 2)

Drug Evaluation (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 3)

Drugs, Investigational (Phase 3)

Drug Therapy (Phase 3)

Drug Therapy, Combination (Phase 1/Phase 2)

Endocrine Gland Neoplasms (Phase 1/Phase 2)

Endocrine System Diseases (Phase 1/Phase 2)

Endodermal Sinus Tumor (Phase 3)

Endometrial Neoplasms (Phase 3)

Endothelium (Phase 2)

Enteral Nutrition (Phase 3)

Enteropathy-Associated T-Cell Lymphoma (Phase 2)

Ependymoma (Phase 3)

Epidermal Growth Factor (Phase 2)

Epstein-Barr Virus Infections (Phase 2/Phase 3)

Esophageal Diseases (Phase 2)

Esophageal Neoplasms (Phase 4)

Esophageal Squamous Cell Carcinoma (Phase 3)

Esophagogastric Junction (Phase 2)

Exploratory Behavior (Phase 2)

Fallopian Tube Neoplasms (Phase 3)

Fatigue (Phase 2)

Gallbladder Neoplasms (Phase 3)

Ganglioneuroblastoma (Phase 3)

Gastrointestinal Neoplasms (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

General Surgery (Phase 3)

Genes, erbB-1 (Phase 2)

Genes, erbB-2 (Phase 3)

Genital Neoplasms, Female (Phase 2)

Genital Neoplasms, Male (Phase 2)

Germinoma (Phase 3)

Gestational Trophoblastic Disease (Phase 3)

Glioblastoma (Phase 2/Phase 3)

Glioma (Phase 3)

Graft vs Host Disease (Phase 2)

Granulocyte-Macrophage Colony-Stimulating Factor (Phase 2)

Hamartoma (Phase 3)

Head and Neck Neoplasms (Phase 4)

Hepatoblastoma (Phase 3)

Histone Deacetylase Inhibitors (Phase 2)

HIV Infections (Phase 2)

Hodgkin Disease (Phase 3)

Homologous Recombination (Phase 2/Phase 3)

Human papillomavirus 16 (Phase 2)

Hydatidiform Mole (Phase 3)

Hyperthermic Intraperitoneal Chemotherapy (Phase 2)

Hypopharyngeal Neoplasms (Phase 3)

Hypoxia (Phase 2)

Hysterectomy (Phase 2)

Immune Checkpoint Inhibitors (Phase 3)

Immune System Diseases (Phase 2)

Immunoglobulin Light-chain Amyloidosis (Phase 2)

Immunoglobulin Light Chains (Phase 2)

Immunoproliferative Disorders (Phase 2)

Immunotherapy (Phase 3)

Induction Chemotherapy (Phase 1)

Inflammatory Breast Neoplasms (Phase 3)

Intestinal Diseases (Phase 1/Phase 2)

Intestinal Neoplasms (Phase 2)

Kidney Failure, Chronic (Phase 1)

Kidney Neoplasms (Phase 2)

Klatskin Tumor (Phase 3)

Laparoscopy (Phase 2)

Laparotomy (Phase 2)

Lapatinib (Phase 2)

Laryngeal Neoplasms (Phase 3)

Leukemia (Phase 2)

Lip Neoplasms (Phase 2)

Liposarcoma (Early Phase 1)

Liver Cirrhosis (Phase 3)

Liver Diseases (Phase 2)

Liver Neoplasms (Phase 3)

Lung (Phase 2)

Lung Diseases (Phase 3)

Lung Neoplasms (Phase 4)

Lymphatic Diseases (Phase 2)

Lymphatic Metastasis (Phase 3)

Lymphohistiocytosis, Hemophagocytic (Phase 4)

Lymphoma (Phase 3)

Lymphoma, AIDS-Related (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 1/Phase 2)

Lymphoma, Follicular (Phase 1/Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Mantle-Cell (Phase 4)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 4)

Lymphoma, T-Cell, Peripheral (Phase 4)

Lymphoproliferative Disorders (Phase 2)

Malaria (Phase 3)

Mediastinal Neoplasms (Phase 3)

Medical Oncology (Phase 1)

Medulloblastoma (Phase 3)

Melanoma (Phase 4)

Mesothelioma (Phase 3)

Mesothelioma, Malignant (Phase 3)

Mouth (Phase 3)

Mouth Neoplasms (Phase 3)

Mucositis (Phase 3)

Multiple Myeloma (Phase 3)

Mutation (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 1/Phase 2)

Nasal Cavity (Phase 2)

Nasopharyngeal Carcinoma (Phase 3)

Nasopharyngeal Diseases (Phase 3)

Nasopharyngeal Neoplasms (Phase 3)

Nausea (Phase 3)

Neoadjuvant Therapy (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasm Recurrence, Local (Phase 3)

Neoplasms (Phase 4)

Neoplasms by Histologic Type (Phase 3)

Neoplasms by Site (Phase 3)

Neoplasms, Connective and Soft Tissue (Phase 2/Phase 3)

Neoplasms, Connective Tissue (Phase 2/Phase 3)

Neoplasms, Germ Cell and Embryonal (Phase 4)

Neoplasms, Glandular and Epithelial (Phase 1/Phase 2)

Neoplasms, Nerve Tissue (Phase 3)

Neoplasms, Squamous Cell (Phase 3)

Neoplasms, Unknown Primary (Phase 2)

Neuroblastoma (Phase 3)

Neuroectodermal Tumors (Phase 3)

Neuroectodermal Tumors, Primitive (Phase 2)

Neuroendocrine Tumors (Phase 2/Phase 3)

Neurotoxicity Syndromes (Phase 1)

Neutropenia (Phase 2)

Nutrition Therapy (Phase 3)

Oncogenes (Phase 1)

Oropharyngeal Neoplasms (Phase 4)

Osteosarcoma (Phase 3)

Ototoxicity (Phase 3)

Ovarian Diseases (Phase 2)

Ovarian Neoplasms (Phase 3)

Paclitaxel (Phase 1)

Pain (Phase 3)

Pancreatic Diseases (Phase 1/Phase 2)

Pancreatic Neoplasms (Phase 4)

Papillomaviridae (Phase 2)

Papillomavirus Infections (Phase 2)

Paranasal Sinuses (Phase 2)

Paranasal Sinus Neoplasms (Phase 3)

Pathology (Phase 2)

Patient Reported Outcome Measures (Phase 2)

Pediatrics (Phase 3)

Penile Neoplasms (Phase 2)

Perioperative Period (Phase 2)

Peritoneal Neoplasms (Phase 3)

Peritoneum (Phase 2)

Pharmacology (Phase 3)

Pharyngeal Diseases (Phase 1/Phase 2)

Pharyngeal Neoplasms (Phase 3)

Pheochromocytoma (Phase 2)

Plasmacytoma (Phase 2)

Pleura (Phase 2)

Pleural Effusion, Malignant (Phase 3)

Pleural Neoplasms (Phase 2)

Positron Emission Tomography Computed Tomography (Phase 2)

Precancerous Conditions (Phase 3)

Progression-Free Survival (Phase 3)

Prostatic Neoplasms (Phase 3)

Prostatic Neoplasms, Castration-Resistant (Phase 1)

Prosthesis Failure (Phase 3)

Quality of Life (Phase 3)

Radiation (Phase 3)

Radiation Oncology (Phase 2)

Radiosurgery (Phase 2)

Radiotherapy (Phase 3)

ras Proteins (Phase 2)

Receptors, Fibroblast Growth Factor (Phase 3)

Receptors, Tumor Necrosis Factor, Type I (Phase 2/Phase 3)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 3)

Respiratory Tract Diseases (Phase 3)

Respiratory Tract Neoplasms (Phase 3)

Retinoblastoma (Phase 3)

Retroperitoneal Neoplasms (Phase 1)

Rhabdoid Tumor (Phase 3)

Rhabdomyosarcoma (Phase 2)

Rituximab (Phase 2)

Salivary Gland Neoplasms (Phase 3)

Sarcoma (Phase 3)

Sarcoma, Ewing (Phase 2)

Seminoma (Phase 3)

Sentinel Lymph Node (Phase 2)

Skin Neoplasms (Phase 3)

Small Cell Lung Carcinoma (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 4)

Stomach Diseases (Phase 1)

Stomach Neoplasms (Phase 3)

Stomatitis (Phase 3)

Survival (Phase 3)

Teratoma (Phase 3)

Testicular Neoplasms (Phase 3)

Therapeutics (Phase 2)

Thoracic Neoplasms (Phase 3)

Thrombocytopenia (Phase 2)

Thymidylate Synthase (Phase 2)

Thymoma (Phase 3)

Thyroid Carcinoma, Anaplastic (Phase 1/Phase 2)

Thyroid Neoplasms (Phase 2)

Tongue Neoplasms (Phase 3)

Triple Negative Breast Neoplasms (Phase 3)

Ureteral Neoplasms (Phase 3)

Urethral Neoplasms (Phase 3)

Urinary Bladder (Phase 2)

Urinary Bladder Neoplasms (Phase 3)

Urogenital Neoplasms (Phase 2)

Urologic Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 4)

Uterine Neoplasms (Phase 3)

Vaginal Neoplasms (Phase 2)

Vinorelbine (Phase 2)

Vulvar Neoplasms (Phase 3)

Waldenstrom Macroglobulinemia (Phase 2)

Wilms Tumor (Phase 1)

Xerostomia (Phase 2)

Yang Deficiency (Phase 2)

Yin Deficiency (Phase 2)